Nanowired Delivery of Growth Hormone Attenuates Pathophysiology of Spinal Cord Injury and Enhances Insulin-Like Growth Factor-1 Concentration in the Plasma and the Spinal Cord

dc.creatorMuresanu D.F.
dc.creatorSharma A.
dc.creatorLafuente J.V.
dc.creatorPatnaik R.
dc.creatorTian Z.R.
dc.creatorNyberg F.
dc.creatorSharma H.S.
dc.date.accessioned2020-09-02T22:24:09Z
dc.date.accessioned2022-11-08T20:18:49Z
dc.date.available2020-09-02T22:24:09Z
dc.date.available2022-11-08T20:18:49Z
dc.date.created2020-09-02T22:24:09Z
dc.date.issued2015
dc.identifier52, 2, 837-845
dc.identifier08937648
dc.identifierhttps://hdl.handle.net/20.500.12728/5515
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/5142897
dc.languageen
dc.publisherHumana Press Inc.
dc.subjectBlood-spinal cord barrier
dc.subjectEdema
dc.subjectGrowth hormone
dc.subjectInsulin-like growth factor-1
dc.subjectSpinal cord injury
dc.subjectEvans blue
dc.subjectgrowth hormone
dc.subjectnanowire
dc.subjectradioactive iodine
dc.subjectsomatomedin C
dc.subjecttitanium dioxide
dc.subjectdrug implant
dc.subjectEvans blue
dc.subjectgrowth hormone
dc.subjectinsulin-like growth factor-1, rat
dc.subjectneuroprotective agent
dc.subjectradioactive iodine
dc.subjectrecombinant protein
dc.subjectsomatomedin C
dc.subjectanimal experiment
dc.subjectanimal tissue
dc.subjectArticle
dc.subjectcontinuous infusion
dc.subjectcontrolled study
dc.subjectdrug delivery system
dc.subjectedema
dc.subjectextravasation
dc.subjectgrowth hormone deficiency
dc.subjecthormone blood level
dc.subjectincision
dc.subjectmale
dc.subjectnerve cell lesion
dc.subjectneuroprotection
dc.subjectnonhuman
dc.subjectpathophysiology
dc.subjectpermeability barrier
dc.subjectrat
dc.subjectspinal cord dorsal horn
dc.subjectspinal cord injury
dc.subjectthoracic spinal cord
dc.subjectanimal
dc.subjectblood
dc.subjectchemistry
dc.subjectcomplication
dc.subjectdrug delivery system
dc.subjectdrug implant
dc.subjectedema
dc.subjectinfusion pump
dc.subjectintraspinal drug administration
dc.subjectnerve cell
dc.subjectpathology
dc.subjectpermeability
dc.subjectspinal cord
dc.subjectSpinal Cord Injuries
dc.subjectSprague Dawley rat
dc.subjectthoracic vertebra
dc.subjecttopical drug administration
dc.subjectvascularization
dc.subjectAdministration, Topical
dc.subjectAnimals
dc.subjectDrug Delivery Systems
dc.subjectDrug Implants
dc.subjectEdema
dc.subjectEvans Blue
dc.subjectGrowth Hormone
dc.subjectInfusion Pumps
dc.subjectInfusions, Spinal
dc.subjectInsulin-Like Growth Factor I
dc.subjectIodine Radioisotopes
dc.subjectMale
dc.subjectNanowires
dc.subjectNeurons
dc.subjectNeuroprotective Agents
dc.subjectPermeability
dc.subjectRats
dc.subjectRats, Sprague-Dawley
dc.subjectRecombinant Proteins
dc.subjectSpinal Cord
dc.subjectSpinal Cord Injuries
dc.subjectThoracic Vertebrae
dc.titleNanowired Delivery of Growth Hormone Attenuates Pathophysiology of Spinal Cord Injury and Enhances Insulin-Like Growth Factor-1 Concentration in the Plasma and the Spinal Cord
dc.typeArticle


Este ítem pertenece a la siguiente institución